Company news

Immix Biopharma, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

IMX-110 + anti-PD-1 Combination Produced Extended Median Survival in Genetic Pancreatic Cancer Mouse Model, Bolstering Planned 2022 IMX-110 Combination Clinical Trial Rationale

January 24, 2022

ImmixBio Announces Positive IMX-110 Phase 1b/2a Interim Clinical Trial Safety Data Demonstrating 100% Completion of Planned Treatment Cycles

January 18, 2022

Immix Biopharma Announces IMMX Investors Day to be Held on February 1, 2022 + Q&A Platform for All Shareholders

January 5, 2022

Immix Biopharma, Inc. Announces Closing of Initial Public Offering

December 19, 2021

Immix Biopharma, Inc. Announces Pricing of Initial Public Offering

December 14, 2021

← Newer news releases

Decks

The 5 newest of 17 decks. Every deck is listed under its year.